Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Armata Pharmaceuticals, Inc. | armp-20191231x10k.htm |
| EX-32.2 - EX-32.2 - Armata Pharmaceuticals, Inc. | armp-20191231ex322100132.htm |
| EX-32.1 - EX-32.1 - Armata Pharmaceuticals, Inc. | armp-20191231ex321571fe7.htm |
| EX-31.2 - EX-31.2 - Armata Pharmaceuticals, Inc. | armp-20191231ex312a2b8a0.htm |
| EX-31.1 - EX-31.1 - Armata Pharmaceuticals, Inc. | armp-20191231ex311630d74.htm |
| EX-21.1 - EX-21.1 - Armata Pharmaceuticals, Inc. | armp-20191231ex21127c4b6.htm |
| EX-4.8 - EX-4.8 - Armata Pharmaceuticals, Inc. | armp-20191231ex48d6b9585.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements of Armata Pharmaceuticals, Inc.:
|
(1) |
Registration Statements (Form S-1 Nos. 333-213421, 333-217169, 333-217680, and 333-226959), |
|
(2) |
Registration Statement (Form S-3 No. 333-210974), |
|
(3) |
Registration Statement (Form S-8 No. 333-203455) pertaining to the 2012 Stock Incentive Plan and 2013 Stock Incentive Plan, |
|
(4) |
Registration Statements (Form S-8 Nos. 333-212183, 333-217563, and 333-223987) pertaining to the Armata Pharmaceuticals, Inc. 2016 Employee Stock Purchase Plan and Armata Pharmaceuticals, Inc. 2016 Equity Incentive Plan, and |
|
(5) |
Registration Statements (Form S-8 No. 333-221564 and 333-232058) pertaining to the Armata Pharmaceuticals, Inc. 2016 Equity Incentive Plan, as amended, C3J Jian, Inc. Amended 2006 Stock Option Plan and C3J Therapeutics, Inc. 2016 Stock Plan; |
of our report dated March 19, 2020, with respect to the consolidated financial statements of Armata Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Armata Pharmaceuticals, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
San Diego, California
March 19, 2020